Biotech/Biomedical
News Category
David Ferrera Urges Focus on Translational Discipline to Bridge Gap Between Medical Device Innovation and Patient Care
David Ferrera, CEO of RC Medical, calls for greater emphasis on translational discipline in medical device innovation, arguing that many promising ide...
High-Pressure Glass Autoclaves Market Projected to Reach USD 355 Million by 2036, Driven by Research Visibility and Green Chemistry
The global high-pressure glass autoclaves market is set to grow from USD 162 million in 2026 to USD 355 million by 2036 at 8.2% CAGR, fueled by demand...
Flow Cytometry Diagnostics Market Poised to Reach $3.5 Billion by 2036, Driven by MRD Testing and Multiparametric Analysis
The global flow cytometry diagnostics market is projected to grow from $1.5 billion in 2026 to $3.5 billion by 2036 at an 8.9% CAGR, fueled by rising ...
GeoVax Reports Q2 2026 Financial Results and Progress on GEO-MVA Pivotal Study
GeoVax advances its GEO-MVA vaccine toward a pivotal immunobridging study under an expedited EMA pathway, while reporting a net loss of $4.4 million f...
VERAXA Biotech Advances Bispecific ADC Program VXA-222 Under OmniAb Collaboration
VERAXA Biotech (VRXA) announced the advancement of its bispecific antibody-drug conjugate program VXA-222 after OmniAb completed discovery work, movin...
Quantum BioPharma Outlines Lucid-MS Development Strategy and Commercial Growth Plans in BioMedWire Podcast
Quantum BioPharma’s executive discusses advancing Lucid-MS for multiple sclerosis into Phase 2 trials and the commercial potential of unbuzzd, highlig...
Onco-Innovations Advances Lead Oncology Candidate ONC010 Toward Clinical Studies
Onco-Innovations is progressing its lead PNKP inhibitor ONC010 through manufacturing scale-up, formulation optimization, and clinical planning, aiming...
Regentis Biomaterials Targets $3 Billion Cartilage Repair Market with GelrinC Regenerative Platform
Regentis Biomaterials is advancing GelrinC, a first-in-class, off-the-shelf cartilage regeneration treatment, to address the growing demand for restor...
Earth Science Tech Reports Strong Fiscal 2026 Results, Highlights Integrated Healthcare Platform
Earth Science Tech Inc. announced fiscal 2026 results with revenue up 8% to $35.7 million, driven by its vertically integrated healthcare model connec...
Culturally Tailored Navajo Medically Tailored Meals Reduce Heart Failure Hospitalizations by Half
A randomized clinical trial found that providing heart failure patients in the Navajo Nation with eight weeks of medically tailored meals incorporatin...
Gold Extends Drop as Traders Await Fed Meeting Amid Inflation Concerns
Gold prices continue to fall as traders anticipate a potential interest rate hike by the Federal Reserve due to energy-driven inflation, impacting min...
Experimental Immunotherapy Shows Promise for Aggressive Pediatric Brain Cancer
Research published in Nature Medicine indicates that experimental immunotherapy may offer relief for patients with aggressive pediatric brain and spin...
American Fusion Inc. Highlights Texatron Technology and GEM Theory at APS Particle Physics Conference
American Fusion Inc. presented its Texatron Fusion Engine and GEM Unification Theory at the APS Division of Particles and Fields meeting, advancing th...
VERAXA Biotech Shareholders Overwhelmingly Approve Corporate Governance and Financing Measures
Shareholders of VERAXA Biotech AG approved key corporate governance and financing proposals with over 99.94% support, providing flexibility for growth...
Tonix Pharmaceuticals Schedules Second-Quarter 2026 Results Call for Aug. 10
Tonix Pharmaceuticals will report Q2 2026 financial results and operational highlights on Aug. 10, 2026, followed by a conference call to discuss rece...
VERAXA Biotech Advances Bispecific ADC Program Under OmniAb Collaboration, Reaching Key Milestone for VXA-222
VERAXA Biotech announced that its bispecific antibody-drug conjugate program VXA-222 has reached a key technical milestone under its collaboration wit...
American Fusion Inc. Achieves Key Certification and Outlines Commercialization Strategy for Texatron Fusion Engine
American Fusion Inc. has received certification from the Texas Department of State Health Services for its Texatron Fusion Engine models, enabling upc...
Onco-Innovations Integrates PNKP Inhibition, Nanoparticle Delivery, and AI to Overcome Key Challenges in Cancer Drug Development
Onco-Innovations is advancing ONC010, a PNKP inhibitor delivered via nanoparticles and supported by AI, to address drug resistance, high clinical tria...
ADAP Advocacy Calls for CMS Oversight of 340B Drug Pricing Program to Enhance Transparency and Patient Benefit
ADAP Advocacy urges transferring oversight of the 340B Drug Pricing Program from HRSA to CMS, citing lack of transparency and enforcement that has all...
CHD Proteins Reveal Stage-Specific Roles in Heart Development, Offering New Insights into Congenital Defects
A comprehensive review synthesizes decades of research to assign distinct, stage-specific functions to CHD chromatin remodelers during heart developme...
Behçet's Spectrum Disorders Framework Offers New Lens for Pediatric Inflammatory Conditions
Researchers propose a tiered genetic classification for Behçet's spectrum disorders to help clinicians recognize Behçet-like inflammation earlier and ...
SS Innovations to Showcase SSi Mantra Surgical Robot at SRS 2026, Highlighting Remote Telesurgery Capabilities
SS Innovations International will present its SSi Mantra surgical robotic system, featuring a live telesurgery broadcast from India, at the Society of...
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC Platform
VERAXA Biotech appoints Christoph Erkel, Ph.D., as chief scientific officer to lead development of its BiTAC platform for cancer therapies targeting s...
Regentis Biomaterials Targets $3 Billion Cartilage Repair Market with GelrinC Platform
Regentis Biomaterials is advancing GelrinC, an off-the-shelf cartilage regeneration platform, to address the $3 billion U.S. cartilage repair market w...
Health Insurance Keeps 25% of US Employees Locked in Their Jobs
A Gallup and West Health poll reveals that nearly 25% of U.S. employees, or about 23 million people, remain in jobs they would leave due to the need t...
OptimumBank Holdings Reports Record $6.7M Net Income in Q2 2026
OptimumBank Holdings announced record quarterly net income of $6.7 million, driven by strong loan and deposit growth, highlighting its robust financia...
NanoViricides Raises $3.8 Million in Registered Direct Offering to Advance Antiviral Drug Development
NanoViricides secures $3.8 million from a fundamental institutional investor through a registered direct offering, funding ongoing clinical trials for...
Premiere Orthodontics Offers Lifetime Guarantee on Braces and Invisalign in Waterford Lakes
Premiere Orthodontics, a board-certified practice in Orlando, now provides a Lifetime Guarantee on all orthodontic treatments, ensuring long-term resu...
Gerresheimer Opens New Plant in Zhenjiang Dagang, Doubling Production Capacity for Injectable Pharma Packaging in China
Gerresheimer has commenced operations at a new, sustainable plant in Zhenjiang Dagang, China, doubling its production capacity for glass primary packa...
VERAXA Biotech Gains Regulatory Support for BiTAC®-TCE Development from Germany's Paul-Ehrlich-Institute
VERAXA Biotech's receipt of Scientific Advice from Germany's Paul-Ehrlich-Institute provides early regulatory guidance for its lead BiTAC®-TCE program...
Onco-Innovations Advances Precision Oncology with ONC010 as Biomarker-Driven Cancer Gains Momentum
Onco-Innovations is developing ONC010, a nanoparticle-encapsulated PNKP inhibitor for biomarker-selected cancers, aligning with the shift toward preci...
American Fusion Expands Texatron Patent Portfolio to 76 U.S. Applications, Accelerating Toward 260 Filings
American Fusion Inc. has filed 19 additional U.S. patent applications for its Texatron Fusion Engine, bringing total filings to 76, as it progresses t...
Recent Outbreaks Reveal Critical Gaps in U.S. Public Health Systems, Experts Say
Recent outbreaks of measles, mpox, and HIV have exposed vulnerabilities in public health infrastructure, prompting companies like Co-Diagnostics Inc. ...
SS Innovations to Showcase SSi Mantra Surgical Robot at SRS 2026, Highlighting Telesurgery and Global Expansion
SS Innovations will present its SSi Mantra robotic system at the SRS 2026 meeting, featuring a live telesurgery broadcast and reporting over 12,375 pr...
Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Cancer Treatment Methods
Lantern Pharma announced a U.S. patent allowance for methods using a three-gene biomarker signature to select and treat patients with ovarian, primary...
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC Platform
VERAXA Biotech AG appointed Christoph Erkel, Ph.D., as chief scientific officer to lead development of its proprietary BiTAC platform technologies for...
Energy Fuels Schedules Q2 2026 Conference Call, Highlighting Critical Materials Production
Energy Fuels Inc. announced its Q2 2026 financial results conference call on August 6, underscoring its role as a leading U.S. producer of uranium and...
iOrganBio Appoints Lee L. Rubin, Ph.D., to Scientific Advisory Board, Enhancing Neurological Expertise
iOrganBio adds leading stem cell biologist Lee L. Rubin to its Scientific Advisory Board, aiming to leverage his expertise in neurodegenerative diseas...
BioAdaptives Completes Manufacturing Readiness for Wellness Product Launch
BioAdaptives has finished commercial manufacturing and logistics setup, positioning it to launch its MyndSystem and Xcellara wellness platforms next m...
Dr. Glen Gillen: The Human Side of Healthcare Cannot Be Replaced by Technology
Dr. Glen Gillen, a renowned occupational therapist and educator, emphasizes that meaningful healthcare must prioritize human connection over technolog...
Creative Biolabs Expands Microfluidics Platform to Accelerate Antibody Discovery
Creative Biolabs has integrated advanced microfluidic technologies to offer a high-throughput, scalable platform for antibody discovery and immune che...
Neurosurgery Spine Robots Market Projected to Reach $4.4 Billion by 2036, Driven by Precision and Minimally Invasive Surgery
The global neurosurgery and spine robots market is expected to grow from $881 million in 2026 to $4.4 billion by 2036, driven by demand for precision-...
ERP Software Blog Names Best Microsoft Dynamics ERP Tools for Business Intelligence & Reporting for 2026
The 2026 list highlights top BI tools for Microsoft Dynamics ERP, enabling better data-driven decisions, and underscores the growing importance of sel...
Self-Powered System Converts Wastewater into Water and Fertilizer
A new closed-loop system uses bioelectricity from wastewater microbes to drive nutrient and water recovery, offering a path toward energy-neutral wast...
Rubean AG's SoftPOS App Reaches 150,000 Active Terminals, Recurring Revenue Expected to Double by 2026
Rubean AG announces its SoftPOS app is now active on over 150,000 terminals, nearly doubling year-over-year, with recurring revenue projected to more ...
Quantum BioPharma Pioneers Dual Strategy Against Neurological Disorders with Lucid-MS and unbuzzd
Quantum BioPharma is advancing a two-pronged approach to tackle multiple sclerosis and alcohol intoxication effects, with Lucid-MS targeting MS throug...
Oncotelic Therapeutics Publishes Preclinical Data Supporting Intravenous Everolimus Formulation Sapu003
Oncotelic Therapeutics announced the publication of preclinical data for its intravenous everolimus formulation Sapu003, which aims to overcome pharma...
NanoViricides Seeks Approval to Launch Phase II Ebola Trial in DRC
NanoViricides has applied for regulatory approval in the DRC to begin a Phase II trial of its oral antiviral NV-387 against the current Bundibugyo ebo...